SJM
36
-2
MU
56
-3
PGR
68
3
KHC
29
-2
BEN
41
-9
STI
15
-5
MCK
73
2
APA
30
5
MRO
50
11
K
42
-3
WM
80
-4
EQT
57
3
IFF
69
13
BXP
52
-2
IP
62
-2
NUE
40
-3
CTSH
49
-2
CRM
57
2
REGN
65
2
FFIV
64
2
SJM
36
-2
MU
56
-3
PGR
68
3
KHC
29
-2
BEN
41
-9
STI
15
-5
MCK
73
2
APA
30
5
MRO
50
11
K
42
-3
WM
80
-4
EQT
57
3
IFF
69
13
BXP
52
-2
IP
62
-2
NUE
40
-3
CTSH
49
-2
CRM
57
2
REGN
65
2
FFIV
64
2
Financhill
Back

Lifecore Biomedical 10K Form

Sell
36

LFCR
Lifecore Biomedical

Last Price:
5.85
Seasonality Move:
3.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LFCR News And Ratings

See the #1 stock for the next 7 days that we like better than LFCR

LFCR Financial Statistics

Sales & Book Value

Annual Sales: $103.27M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $-0.06
Price / Book: 0

Profitability

EPS (TTM): -3.32000
Net Income (TTM): $-100.12M
Gross Margin: $27.99M
Return on Equity: 0%
Return on Assets: 0%

Lifecore Biomedical Earnings Forecast

Key Lifecore Biomedical Financial Ratios

  • The Gross Profit Margin over the past 28 years for LFCR is 27.10%.
  • The Selling, General & Administrative Expenses for LFCR have been equal to 37.74% of Gross Profit Margin.
  • The Research & Development expenses have been 8.46% of Revenue.
  • The Interest Expense is -17.73% of Operating Income.
  • The Net Earning history of LFCR is -96.41% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 14 years.

Lifecore Biomedical Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: LFCR
Website: lifecore.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

LFCR Technical Analysis vs Fundamental Analysis

Sell
36
Lifecore Biomedical (LFCR) is a Sell

Is Lifecore Biomedical a Buy or a Sell?